ไบเออร์ เชริง ฟาร์มา

ขนาดตัวหนังสือ

คลิกเพื่อปรับขนาด

เครื่องมือของเว็บ

ค้นหา

ลิ้งค์แต่ละประเทศ

Your opinion counts

Financial Report

Stockholders' Newsletter Third Quarter 2007

Image: Face. Text information: Medial progress for the benefit of the patient

วิธีเฉพาะทาง สำหรับความต้องการเฉพาะบุคคล

The future of medicine lies in individual approaches and in building bridges between prevention, diagnosis and therapy. Bayer Schering Pharma meets this challenge with proven, successful products based on many decades of knowledge and experience. เพิ่มเติม

BENEFIT Follow-Up Study Early Treatment of MS Can Delay Permanent Disabilities. Treating patients who are showing the first signs of multiple sclerosis with beta interferon significantly delays the onset of clinically estab-lished MS and the occurrence of permanent disabilities. These are the results of a follow-up to the BENEFIT study recently published in the prestigious journal The Lancet. เพิ่มเติม

Image: medical scientist with patient, MRI

Medical Progress for the Benefit of the Patient Learn more about the health topic Diagnostic Imaging and the activities of Bayer Schering Pharma

เครือข่ายของไบเออร์ เชริง ฟาร์มา

Websites for Consumers, Patients and Healthcare Professionals

These sites provide patients, their families and medical experts with useful information on our products and areas of research, as well as references to further, country-specific Websites.

cardio.bayer.com

www.female-healthcare.com

www.infections.bayer.com

www.male-healthcare.com

www.ms-gateway.com

www.schering-diagnostics.de

www.world-of-flame.info